# Suzhou Xishan Zhongke Drug R&D, Co. Ltd. – FDA Inspection, May 10, 2024

Source: https://www.keypedia.com/records/fda_inspections/suzhou-xishan-zhongke-drug-rd-co-ltd/6ce9003a-7162-444d-9440-b96289a68b36
Source feed: FDA_Inspections

> FDA inspection 1240347 of Suzhou Xishan Zhongke Drug R&D, Co. Ltd., May 10, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 58. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240347
- Company Name: Suzhou Xishan Zhongke Drug R&D, Co. Ltd.
- Inspection Date: 2024-05-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Officers

- [Investigator](https://www.keypedia.com/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)
- [Company Rep](https://www.keypedia.com/people/mark-j-seaton/640c2deb-25ff-4e2e-8f48-d15d31f9c5bf)
- [Company Rep](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)

Company: https://www.keypedia.com/companies/suzhou-xishan-zhongke-drug-rd-co-ltd/dc890450-dcf3-4418-9b62-8b22b6de1182

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8